Nuclear Medicine Department, The General Hospital of the Chinese People's Liberation Army and Military Medical Postgraduate College, 28 Fuxing Road, Haidian District, Beijing 100853, China.
World J Gastroenterol. 2010 Nov 21;16(43):5416-23. doi: 10.3748/wjg.v16.i43.5416.
To monitor the early responses to irradiation in primary and metastatic colorectal cancer (CRC) with (18)F-fluorothymidine ((18)F-FLT) and (18)F-fluorodeoxyglucose ((18)F-FDG) small-animal position emission tomography (micro-PET).
The primary and metastatic CRC cell lines, SW480 and SW620, were irradiated with 5, 10 and 20 Gy. After 24 h, the cell cycle phases were analyzed. A dual-tumor-bearing mouse model of primary and metastatic cancer was established by injecting SW480 and SW620 cells into mice. micro-PET with (18)F-FLT and (18)F-FDG was performed before and 24 h after irradiation with 5, 10 and 20 Gy. The region of interest (ROI) was drawn over the tumor and background to calculate the ratio of tumor to non-tumor (T/NT) in tissues. Immunohistochemical assay and Western blotting were used to examine the levels of integrin β(3,) Ki-67, vascular endothelial growth factor receptor 2 (VEGFR2) and heat shock protein 27 (HSP27).
The proportion of SW480 and SW620 cells in the G(2)-M phase was decreased with an increasing radiation dose. The proportion of SW480 cells in the G(0)-G(1) phase was increased from 48.33% ± 4.55% to 87.09% ± 7.43% (P < 0.001) and that of SW620 cells in the S-phase was elevated from 43.57% ± 2.65% to 66.59% ± 7.37% (P = 0.021). In micro-PET study, with increasing dose of radiation, (18)F-FLT uptake was significantly reduced from 3.65 ± 0.51 to 2.87 ± 0.47 (P = 0.008) in SW480 tumors and from 2.22 ± 0.42 to 1.76 ± 0.45 (P = 0.026) in SW620 tumors. (18)F-FDG uptake in SW480 and SW620 tumors was reduced but not significantly (F = 0.582, P = 0.633 vs F = 0.273, P = 0.845). Dose of radiation was negatively correlated with (18)F-FLT uptake in both SW480 and SW620 tumors (r = -0.727, P = 0.004; and r = -0.664, P = 0.009). No significant correlation was found between (18)F-FDG uptake and radiation dose in SW480 or SW620 tumors. HSP27 and integrin β(3) expression was higher in SW480 than in SW620 tumors. The T/NT ratio for (18)F-FLT uptake was positively correlated with HSP27 and integrin β(3) expression (r = 0.924, P = 0.004; and r = 0.813, P = 0.025).
(18)F-FLT is more suitable than (18)F-FDG in monitoring early responses to irradiation in both primary and metastatic lesions of colorectal cancer.
使用(18)F-氟代胸苷((18)F-FLT)和(18)F-氟代脱氧葡萄糖((18)F-FDG)小动物正电子发射断层扫描(micro-PET)监测原发性和转移性结直肠癌(CRC)的早期放射反应。
用 5、10 和 20 Gy 照射 SW480 和 SW620 原发性和转移性 CRC 细胞系。24 h 后,分析细胞周期阶段。通过将 SW480 和 SW620 细胞注射到小鼠中,建立原发性和转移性癌症的双重肿瘤荷瘤小鼠模型。在 5、10 和 20 Gy 照射前后进行(18)F-FLT 和(18)F-FDG 的 micro-PET。在肿瘤和背景上画出感兴趣区域(ROI),以计算组织中的肿瘤与非肿瘤(T/NT)比值。使用免疫组织化学检测和 Western blot 检测整合素β(3)、Ki-67、血管内皮生长因子受体 2(VEGFR2)和热休克蛋白 27(HSP27)的水平。
SW480 和 SW620 细胞在 G(2)-M 期的比例随着辐射剂量的增加而降低。SW480 细胞在 G(0)-G(1)期的比例从 48.33%±4.55%增加到 87.09%±7.43%(P<0.001),SW620 细胞在 S 期的比例从 43.57%±2.65%增加到 66.59%±7.37%(P=0.021)。在 micro-PET 研究中,随着辐射剂量的增加,SW480 肿瘤中(18)F-FLT 的摄取从 3.65±0.51 显著减少到 2.87±0.47(P=0.008),SW620 肿瘤中从 2.22±0.42 减少到 1.76±0.45(P=0.026)。SW480 和 SW620 肿瘤中(18)F-FDG 的摄取减少但不显著(F=0.582,P=0.633 与 F=0.273,P=0.845)。辐射剂量与 SW480 和 SW620 肿瘤中(18)F-FLT 的摄取呈负相关(r=-0.727,P=0.004;和 r=-0.664,P=0.009)。在 SW480 或 SW620 肿瘤中,(18)F-FDG 摄取与辐射剂量之间未发现显著相关性。SW480 肿瘤中 HSP27 和整合素β(3)的表达高于 SW620 肿瘤。(18)F-FLT 摄取的 T/NT 比值与 HSP27 和整合素β(3)的表达呈正相关(r=0.924,P=0.004;和 r=0.813,P=0.025)。
与(18)F-FDG 相比,(18)F-FLT 更适合监测原发性和转移性结直肠癌的早期放射反应。